BioCardia (BCDA) Short Interest Ratio & Short Volume $2.26 +0.12 (+5.61%) (As of 11/22/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainSEC FilingsShort InterestTrends BioCardia Short Interest DataBioCardia (BCDA) has a short interest of 86,300 shares, representing 3.17% of the float (the number of shares available for trading by the public). This marks a 72.60% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 60,268 shares to cover all short positions.Current Short Interest86,300 sharesPrevious Short Interest50,000 sharesChange Vs. Previous Month+72.60%Dollar Volume Sold Short$201,079.00Short Interest Ratio0.1 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares4,584,000 sharesFloat Size2,720,000 sharesShort Percent of Float3.17%Today's Trading Volume30,704 sharesAverage Trading Volume60,268 sharesToday's Volume Vs. Average51% Short Selling BioCardia? Sign up to receive the latest short interest report for BioCardia and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartBCDA Short Interest Over TimeBCDA Days to Cover Over TimeBCDA Percentage of Float Shorted Over Time Ad StockEarnings9 hidden AI stocks set to thrive in Trump’s new eraAI ETFs are Booming, But These 9 AI Stocks are Better Plays By 2030, the AI industry is projected to be worth trillions of dollars (here’s how to tap into this new wealth)Get the Name of These AI Picks Now BioCardia Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/202486,300 shares $201,079.00 +72.6%3.2%0.1 $2.33 10/15/202450,000 shares $122,000.00 -62.2%1.8%0.1 $2.44 9/30/2024132,100 shares $412,152.00 -12.6%4.8%0.2 $3.12 9/15/2024151,200 shares $449,064.00 -91.7%6.4%0.2 $2.97 8/31/20241,830,000 shares $5.58 million +2,719.7%84.3%2.3 $3.05 8/15/202464,900 shares $188,210.00 +104.1%4.3%0.4 $2.90 Get the Latest News and Ratings for BCDA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BioCardia and its competitors with MarketBeat's FREE daily newsletter. 7/31/202431,800 shares $95,718.00 +8.2%2.5%0.2 $3.01 7/15/202429,400 shares $104,076.00 -38.8%2.3%0.2 $3.54 6/30/202448,000 shares $142,560.00 -37.7%3.7%0.4 $2.97 6/15/202477,100 shares $262,911.00 +267.1%6.0%0.6 $3.41 5/31/202421,000 shares $97,020.00 -91.1%1.6%0.2 $4.62 5/15/2024235,400 shares $92,041.40 -10.4%N/A0.7 $0.39 4/30/2024262,800 shares $101,729.88 -3.1%N/A0.8 $0.39 4/15/2024271,200 shares $100,994.88 -49.4%N/A0.8 $0.37 3/31/2024535,900 shares $218,111.30 -46.9%N/A1.4 $0.41 3/15/20241,010,000 shares $393,900.00 +927.5%6.2%2.7 $0.39 2/29/202498,300 shares $54,065.00 -67.0%0.7%0.3 $0.55 2/15/2024297,600 shares $127,968.00 +84.2%2.5%1 $0.43 1/31/2024161,600 shares $73,237.12 +22.8%1.3%0.1 $0.45 1/15/2024131,600 shares $85,329.44 -39.2%1.1%0 $0.65 12/31/2023216,600 shares $143,865.72 -31.8%1.8%0.1 $0.66 12/15/2023317,800 shares $190,997.80 -9.0%2.7%0.1 $0.60 11/30/2023349,100 shares $216,860.92 +132.0%3.5%0.1 $0.62 11/15/2023150,500 shares $142,222.50 +13.4%1.5%0.1 $0.95 10/31/2023132,700 shares $49,404.21 -35.2%1.3%1.2 $0.37 10/15/2023204,900 shares $90,156.00 +9.8%2.1%1.5 $0.44 9/30/2023186,600 shares $80,219.34 +48.1%1.6%1.4 $0.43 9/15/2023126,000 shares $49,770.00 -36.7%1.1%0.9 $0.40 8/31/2023199,000 shares $155,220.00 +8.0%1.7%1.8 $0.78 8/15/2023184,300 shares $162,147.14 +575.1%1.5%1.9 $0.88 7/31/202327,300 shares $28,119.00 -84.0%0.2%0.3 $1.03 7/15/2023171,000 shares $398,430.00 -14.2%1.4%2.4 $2.33 6/30/2023199,400 shares $532,398.00 -4.3%1.6%5.1 $2.67 6/15/2023208,300 shares $477,007.00 +3.8%1.6%5.6 $2.29 5/31/2023200,600 shares $355,062.00 +1,443.1%1.6%6.9 $1.77 5/15/202313,000 shares $24,050.00 -29.4%0.1%0.5 $1.85 4/30/202318,400 shares $37,904.00 -12.0%0.1%0.9 $2.06 4/15/202320,900 shares $40,964.00 -23.7%0.1%0.9 $1.96 3/31/202327,400 shares $53,430.00 -26.9%0.2%1 $1.95 3/15/202337,500 shares $73,875.00 +4.8%0.3%1.2 $1.979 hidden AI stocks set to thrive in Trump’s new era (Ad)AI ETFs are Booming, But These 9 AI Stocks are Better Plays By 2030, the AI industry is projected to be worth trillions of dollars (here’s how to tap into this new wealth)Get the Name of These AI Picks Now 2/28/202335,800 shares $78,760.00 +96.7%0.3%0.7 $2.20 2/15/202318,200 shares $40,586.00 -56.6%0.1%0.4 $2.23 1/31/202341,900 shares $106,426.00 -4.3%0.3%0.9 $2.54 1/15/202343,800 shares $100,302.00 -15.4%0.4%1 $2.29 12/30/202251,800 shares $108,262.00 -40.6%0.4%1.2 $2.09 12/15/202287,200 shares $149,112.00 +149.1%0.7%2 $1.71 11/30/202235,000 shares $64,750.00 +44.0%0.2%0.8 $1.85 11/15/202224,300 shares $45,684.00 -42.1%0.2%0.5 $1.88 10/31/202242,000 shares $81,900.00 -24.5%0.3%0.7 $1.95 10/15/202255,600 shares $116,204.00 -37.3%0.4%0.9 $2.09 9/30/202288,600 shares $171,884.00 -7.2%0.7%1.4 $1.94 9/15/202295,500 shares $193,865.00 -2.7%0.7%1.6 $2.03 8/31/202298,100 shares $195,219.00 +182.7%0.7%1.4 $1.99 8/15/202234,700 shares $58,296.00 -42.1%0.3%0.7 $1.68 7/31/202259,900 shares $86,855.00 -25.7%0.5%1.2 $1.45 7/15/202280,600 shares $124,930.00 -47.7%0.8%1.2 $1.55 6/30/2022154,200 shares $223,590.00 -29.3%1.6%0.2 $1.45 6/15/2022218,100 shares $307,521.00 -42.2%2.3%0.3 $1.41 5/31/2022377,300 shares $633,864.00 -2.8%2.9%0.6 $1.68 5/15/2022388,200 shares $543,480.00 -38.1%3.0%0.6 $1.40 4/30/2022627,000 shares $965,580.00 -49.8%5.0%0.7 $1.54 4/15/20221,250,000 shares $1.86 million +150.1%10.0%0.7 $1.49 3/31/2022499,900 shares $1.03 million -5.7%4.0%0.4 $2.07 3/15/2022530,100 shares $1.03 million -10.4%4.2%0.4 $1.95 2/28/2022591,700 shares $1.22 million -45.2%4.7%0.4 $2.07 2/15/20221,080,000 shares $2.39 million +425.3%8.5%0.8 $2.21 1/31/2022205,600 shares $380,360.00 -7.3%1.6%0.2 $1.85 1/15/2022221,700 shares $390,192.00 -13.8%1.7%1.5 $1.76 12/31/2021257,300 shares $499,162.00 +57.5%2.0%1.8 $1.94 12/15/2021163,400 shares $281,048.00 -30.9%1.3%1.2 $1.72 11/30/2021236,300 shares $484,415.00 -10.0%1.9%1.7 $2.05 11/15/2021262,600 shares $643,370.00 -10.5%2.1%1.9 $2.45 10/29/2021293,300 shares $821,240.00 +3.8%2.3%2.1 $2.80 10/15/2021282,700 shares $828,311.00 +8.7%2.2%2 $2.93 9/30/2021260,000 shares $816,400.00 +33.2%2.0%1.8 $3.14 9/15/2021195,200 shares $554,368.00 -0.9%1.5%1.4 $2.84 8/31/2021197,000 shares $581,150.00 -34.0%1.6%2.8 $2.95 8/13/2021298,300 shares $924,730.00 +5.3%2.3%4 $3.10 7/30/2021283,400 shares $940,888.00 -13.8%2.2%3.8 $3.32 7/15/2021328,900 shares $1.11 million -10.7%2.6%4.2 $3.36 6/30/2021368,200 shares $1.46 million +2.1%2.9%4.2 $3.97 6/15/2021360,500 shares $1.60 million -20.0%2.8%3.4 $4.43 5/28/2021450,400 shares $1.84 million +4.9%3.6%4.3 $4.09 5/14/2021429,300 shares $1.43 million +2.0%N/A3.6 $3.32 4/30/2021420,900 shares $1.49 million -0.2%N/A2.6 $3.54 4/15/2021421,900 shares $1.73 million -7.9%N/A1.8 $4.09 3/31/2021458,300 shares $1.82 million +68.4%N/A1.5 $3.98 3/15/2021272,200 shares $1.09 million +25.3%N/A0.5 $4.00 2/26/2021217,300 shares $873,546.00 +0.5%N/A0.1 $4.02 2/12/2021216,200 shares $1.08 million -63.5%N/A0.1 $4.989 hidden AI stocks set to thrive in Trump’s new era (Ad)AI ETFs are Booming, But These 9 AI Stocks are Better Plays By 2030, the AI industry is projected to be worth trillions of dollars (here’s how to tap into this new wealth)Get the Name of These AI Picks Now 1/29/2021591,600 shares $2.48 million -33.8%N/A0.2 $4.20 1/15/2021894,200 shares $3.35 million +49.8%N/A0.2 $3.75 12/31/2020597,100 shares $2.10 million +4,715.3%N/A0.2 $3.52 12/15/202012,400 shares $55,552.00 +9.7%N/A0 $4.48 11/30/202011,300 shares $26,555.00 -6.6%N/A0.2 $2.35 11/15/202012,100 shares $26,257.00 -57.4%N/A0.2 $2.17 10/30/202028,400 shares $58,220.00 +3.7%N/A0.3 $2.05 10/15/202027,400 shares $64,664.00 -9.9%N/A0.3 $2.36 9/30/202030,400 shares $69,008.00 +237.8%N/A0.3 $2.27 9/15/20209,000 shares $21,375.00 -61.9%N/A0 $2.38 BCDA Short Interest - Frequently Asked Questions What is BioCardia's current short interest? Short interest is the volume of BioCardia shares that have been sold short but have not yet been covered or closed out. As of October 31st, traders have sold 86,300 shares of BCDA short. 3.17% of BioCardia's shares are currently sold short. Learn More on BioCardia's current short interest. What is a good short interest percentage for BioCardia? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.17% of BioCardia's floating shares are currently sold short. Is BioCardia's short interest increasing or decreasing? BioCardia saw a increase in short interest in the month of October. As of October 31st, there was short interest totaling 86,300 shares, an increase of 72.6% from the previous total of 50,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is BioCardia's float size? BioCardia currently has issued a total of 4,584,000 shares. Some of BioCardia's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. BioCardia currently has a public float of 2,720,000 shares. How does BioCardia's short interest compare to its competitors? 3.17% of BioCardia's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to BioCardia: Cognition Therapeutics, Inc. (2.41%), Bullfrog AI Holdings, Inc. (4.76%), Flora Growth Corp. (9.66%), Marinus Pharmaceuticals, Inc. (10.26%), Cara Therapeutics, Inc. (2.06%), Tenax Therapeutics, Inc. (3.55%), Synlogic, Inc. (0.76%), Mannatech, Incorporated (0.19%), Aprea Therapeutics, Inc. (0.61%), Minerva Neurosciences, Inc. (0.13%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short BioCardia stock? Short selling BCDA is an investing strategy that aims to generate trading profit from BioCardia as its price is falling. BCDA shares are trading up $0.12 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against BioCardia? A short squeeze for BioCardia occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BCDA, which in turn drives the price of the stock up even further. How often is BioCardia's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BCDA, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies Cognition Therapeutics Short Interest Bullfrog AI Short Interest Flora Growth Short Interest Marinus Pharmaceuticals Short Interest Cara Therapeutics Short Interest Tenax Therapeutics Short Interest Synlogic Short Interest Mannatech Short Interest Aprea Therapeutics Short Interest Minerva Neurosciences Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BCDA) was last updated on 11/24/2024 by MarketBeat.com Staff From Our PartnersNew post-election stock warning from Wall StreetIf you’re holding U.S. stocks, it may be time to brace for impact. The S&P 500 crossed 6,000 for the first ...Chaikin Analytics | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredPopular Stocks at Risk Under Trump—Are You Holding These?The Stocks Most At-Risk from Trump’s Victory Free e-book reveals sectors – and stocks within them – likely ...StockEarnings | SponsoredAre Your Retirement Savings Really Safe?What They Don’t Want You to Know About Your 401(k)The 2008-2010 crisis wiped out almost 50% of the value of retirement funds. If you knew it was coming, wouldn'...American Hartford Gold | SponsoredDonald Trump can’t save you from this crisisElon Musk: “This Is The Most Destructive Force In History” Elon Musk claims a terrifying new economic force...Wide Moat Research | SponsoredThe Biggest Post-Election Market Shift Ever?Our No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredA “Thank You Gift” From Pres. Trump - GeniusTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioCardia, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioCardia With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.